Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2019 3
2020 5
2021 2
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Schönegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R. Klampfl T, et al. Among authors: casetti ic. N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10. N Engl J Med. 2013. PMID: 24325356 Free article.
COVID-19 in Patients with Hematologic Diseases.
Casetti IC, Borsani O, Rumi E. Casetti IC, et al. Biomedicines. 2022 Nov 29;10(12):3069. doi: 10.3390/biomedicines10123069. Biomedicines. 2022. PMID: 36551825 Free PMC article. Review.
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.
Ibarra J, Elbanna YA, Kurylowicz K, Ciboddo M, Greenbaum HS, Arellano NS, Rodriguez D, Evers M, Bock-Hughes A, Liu C, Smith Q, Lutze J, Baumeister J, Kalmer M, Olschok K, Nicholson B, Silva D, Maxwell L, Dowgielewicz J, Rumi E, Pietra D, Casetti IC, Catricala S, Koschmieder S, Gurbuxani S, Schneider RK, Oakes SA, Elf SE. Ibarra J, et al. Among authors: casetti ic. Blood Cancer Discov. 2022 Jul 6;3(4):298-315. doi: 10.1158/2643-3230.BCD-21-0144. Blood Cancer Discov. 2022. PMID: 35405004 Free PMC article.
Isolated congenital asplenia: An overlooked cause of thrombocytosis.
Borsani O, Asano T, Boisson B, Fraticelli S, Braschi-Amirfarzan M, Pietra D, Casetti IC, Vanni D, Trotti C, Borghesi A, Casanova JL, Arcaini L, Rumi E. Borsani O, et al. Among authors: casetti ic. Am J Hematol. 2022 Aug;97(8):1110-1115. doi: 10.1002/ajh.26522. Epub 2022 Mar 17. Am J Hematol. 2022. PMID: 35266186 Free PMC article.
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.
Borsani O, Bastard P, Rosain J, Gervais A, Sant'Antonio E, Vanni D, Casetti IC, Pietra D, Trotti C, Catricalà S, Ferretti VV, Malcovati L, Arcaini L, Casanova JL, Borghesi A, Rumi E. Borsani O, et al. Among authors: casetti ic. Blood. 2022 Apr 28;139(17):2716-2720. doi: 10.1182/blood.2021014890. Blood. 2022. PMID: 35100354 Free PMC article. No abstract available.
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.
Rumi E, Zibellini S, Boveri E, Cavalloni C, Riboni R, Casetti IC, Ciboddo M, Trotti C, Favaron C, Pietra D, Candido C, Ferretti VV, Cazzola M, Arcaini L. Rumi E, et al. Among authors: casetti ic. Am J Hematol. 2019 Jul;94(7):E185-E188. doi: 10.1002/ajh.25489. Epub 2019 May 1. Am J Hematol. 2019. PMID: 30972817 Free article. Clinical Trial. No abstract available.
15 results